Victory Capital Management Inc. Grows Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Victory Capital Management Inc. boosted its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD) by 124.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,673 shares of the medical instruments supplier’s stock after purchasing an additional 1,482 shares during the quarter. Victory Capital Management Inc. owned about 0.08% of Utah Medical Products worth $179,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. BNP Paribas Financial Markets increased its stake in shares of Utah Medical Products by 101.7% during the fourth quarter. BNP Paribas Financial Markets now owns 3,766 shares of the medical instruments supplier’s stock worth $317,000 after acquiring an additional 1,899 shares during the period. Advisory Services Network LLC raised its stake in shares of Utah Medical Products by 47.8% during the fourth quarter. Advisory Services Network LLC now owns 4,885 shares of the medical instruments supplier’s stock valued at $411,000 after purchasing an additional 1,579 shares during the period. Isthmus Partners LLC lifted its stake in shares of Utah Medical Products by 6.5% in the fourth quarter. Isthmus Partners LLC now owns 22,699 shares of the medical instruments supplier’s stock worth $1,912,000 after acquiring an additional 1,392 shares in the last quarter. Penn Mutual Asset Management LLC increased its holdings in Utah Medical Products by 46.3% during the 4th quarter. Penn Mutual Asset Management LLC now owns 53,093 shares of the medical instruments supplier’s stock worth $4,471,000 after purchasing an additional 16,810 shares during the last quarter. Finally, Ranger Investment Management L.P. raised its position in shares of Utah Medical Products by 4.3% in the 4th quarter. Ranger Investment Management L.P. now owns 77,591 shares of the medical instruments supplier’s stock valued at $6,535,000 after purchasing an additional 3,180 shares in the last quarter. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Stock Performance

UTMD opened at $66.73 on Wednesday. The company has a 50-day moving average of $68.04 and a 200-day moving average of $68.16. Utah Medical Products, Inc. has a 1-year low of $65.60 and a 1-year high of $89.15. The company has a market capitalization of $235.42 million, a P/E ratio of 14.83 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD) last posted its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 EPS for the quarter. Utah Medical Products had a return on equity of 12.41% and a net margin of 33.56%. The company had revenue of $10.40 million during the quarter.

Utah Medical Products Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 4th. Investors of record on Friday, September 20th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend is Friday, September 20th. Utah Medical Products’s payout ratio is currently 26.67%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.